The effect of food on the pharmacokinetics of the bicalutamide ('Casodex') enantiomers

Biopharmaceutics and Drug Disposition

Volumn 18, Issue 6, 1997, Pages 499-507

  Cockshott, I D ^a   Oliver, S D ^b   Young, J J ^a   Cooper, K J ^a   Jones, D C ^a  

^a ASTRAZENECA   (United Kingdom)

^b Besselaar Clinical Research Unit   (United Kingdom)

Author keywords

'Casodex'; Bicalutamide; Food; Pharmacokinetics

Indexed keywords

BICALUTAMIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; ENANTIOMER; FOOD DRUG INTERACTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; ANDROGEN ANTAGONISTS; ANILIDES; ANIMALS; AREA UNDER CURVE; DIETARY FATS; EATING; FASTING; FOOD-DRUG INTERACTIONS; HUMANS; INTESTINAL ABSORPTION; MALE; MIDDLE AGED; RATS; STEREOISOMERISM;

EID: 0030744475     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199708)18:6<499::AID-BDD37>3.0.CO;2-J     Document Type: Article

References (15)

1. B. J. A. Furr, G. Blackledge and I. D. Cockshott, Casodex, preclinical and clinical studies. In Hormone-Dependent Cancer, J. R. Pasqualini and B. S. Katzenellenbogen (Eds), Marcel Dekker, New York, 1996, pp. 397-424.
2. D. McKillop, G. W. Boyle, I. D. Cockshott, D. C. Jones, P. J. Phillips and R. A. Yates, Metabolism and enantioselective pharmacokinetics of Casodex in man. Xenobiotica, 23, 1241-1253 (1993).
3. I. D. Cockshott, E. A. Sotaniemi, K. J. Cooper and D. C. Jones, The pharmacokinetics of Casodex enantiomers in subjects with impaired liver function. Br. J. Clin. Pharmacol., 36, 339-343 (1993).
4. I. D. Cockshott, K. J. Cooper, D. S. Sweetmore, N. J. Blacklock and L. Denis, The pharmacokinetics of Casodex in prostate cancer patients after single and during multiple dosing. Eur. Urol., 18 (suppl. 3) , 10-17 (1990).
5. C. J. Tyrrell, L. Denis, D. Newling, M. Soloway, K. Channer and I. D. Cockshott, Casodex 10-200 mg daily, used a monotherapy for the treatment of patients with advanced prostate cancer; an overview of the efficacy, tolerability and pharmacokinetics from three dose ranging studies. Eur. Urol., in press.
6. C. D. Allen, MODFIT: a pharmacokinetics computer program. Biopharm. Drug Disposit., 11, 477-498 (1990).
7. D. C. Taylor, R. E. Pownall and W. M. Burke, The absorption of β-adrenoceptor antagonists in rat in situ small intestine; the effect of lipophilicity. J. Pharm. Pharmacol., 37, 280-283 (1985).
8. S. G. Proudfoot, Factors affecting bioavailability: factors influencing drug absorption from the gastrointestinal tract. In Pharmaceutics: the Science of Dosage Form Design, M. E. Aulton (Ed.), Churchill Livingstone, Edinburgh, 1991, pp. 135-173.
9. D. McKillop, P. J. Simons, I. D. Cockshott, S. J. Hill, J. R. Harding, K. J. Cooper and D. C. Jones, Enantioselective metabolism and pharmacokinetics of Casodex in the male rat. Xenobiotica, 25, 623-634 (1995).
10. G. W. Boyle, D. McKillop, P. J. Phillips, J. R. Harding, R. Pickford and A. D. McCormick, Metabolism of Casodex in laboratory animals. Xenobiotica, 23, 781-798 (1993).
11. L. Williams, J. A. Davis and D. T. Lowenthal, The influence of food on the absorption and metabolism of drugs. Med. Clin. North Am., 77, 815-829 (1993).
12. P. J. Neuvonen and K. T. Kivistö, The clinical significance of food - drug interactions: a review. Med. J. Aust., 150, 36-40 (1989).
13. P. G. Welling, Interactions affecting drug absorption. Clin. Pharm., 9, 404-434 (1984).
14. P. G. Welling, Effects of food on drug absorption. Pharmacol. Ther., 43, 425-441 (1989).
15. P. E. Rolan, A. J. Mercer, B. C. Weatherley, T. Holdich, H. Meire, R. W. Peck, G. Ridout and J. Posner, Examination of some factors responsible for a food induced increase in absorption of atovaquone. Br. J. Clin. Pharmacol., 37, 13-20 (1994).